要减肥的夜天
Lv1
40 积分
2024-11-05 加入
-
Targeting IL‐4/IL‐13 Pathways in Angiolymphoid Hyperplasia With Eosinophilia: A Case Report
6小时前
求助中
-
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
8天前
已完结
-
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
2个月前
已完结
-
ST segment and T wave abnormalities: A narrative review
2个月前
已完结
-
Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management?
3个月前
已完结
-
Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis
6个月前
已完结
-
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
6个月前
已完结
-
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
6个月前
已完结
-
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
6个月前
已完结
-
GLP-1 Receptor Agonists and Gastrointestinal Adverse Events
7个月前
已完结